Abstracts

1029 – Rapid Waning in Hepatitis B Virus Vaccine Immunity Among Children HIV-Exposed Uninfected in Botswana

Background The impact of perinatal HIV exposure on children’s immune response to the hepatitis B virus (HBV) vaccine over time has yet to be fully understood. We determined the HBV prevalence in mother-child pairs and HBV vaccine response in children HIV-exposed uninfected (cHEU) and those unexposed uninfected (cHUU) over time in Botswana. Methods Mother-child specimens…

1014 – LA-ART for Breastfeeding Women With HIV in Zimbabwe: Clinical Impact and Cost-Effectiveness

Background Long-acting injectable ART (LA-ART) may reduce barriers to medication adherence for postpartum women with HIV (PPWH) and thus reduce vertical transmission (VT) and improve health outcomes. With CEPAC, a validated computer model of mother-child pairs, we estimated the clinical outcomes and cost-effectiveness of LA-ART for breastfeeding PPWH with adherence challenges to oral ART in…

997 – Perinatal and Infant Outcomes After Bictegravir Exposure in Pregnancy: A Canadian Surveillance Study

Background In January 2024, bictegravir (BIC) was upgraded to an alternative antiretroviral therapy in pregnancy in the United States despite limited data. Our study aimed to examine the perinatal and early infant outcomes following BIC exposure in pregnancy in Canada.  Methods Data was obtained from the Canadian Perinatal HIV Surveillance Program, which is a prospective…

1007 – STI Testing Is Associated With Lower PrEP Discontinuation Among Women Initiating PrEP in Pregnancy

Background Sexually transmitted infections (STIs) in pregnancy contribute to adverse birth outcomes and increased HIV acquisition during pregnancy and the postpartum period. Yet, few studies evaluate how STI testing influences HIV PrEP use among pregnant women who initiate HIV PrEP. Methods We analyzed data from a randomized trial conducted between February 2022-July 2023 among pregnant…

1002 – Immune Markers During Pregnancy and Birth Outcomes in South African WLH

Background There are few insights into the immunological predictors of pregnancy outcomes, including preterm delivery (PTD) and small-for-gestational age (SGA), in women living with HIV (WLH). Methods We followed ART-eligible pregnant WLH attending primary care in Cape Town from their first antenatal visit through to delivery. C-reactive protein (CRP), interferon gamma-induced protein 10 (IP10), and…

988 – Prior Pregnancy Affects Aging-Related Non-AIDS Comorbidity Burden in US Women With and Without HIV

Background Women vs men with HIV have a higher burden of aging-related multimorbidity, which may be related to reproductive transitions including pregnancy history. Methods We evaluated longitudinal data collected from women with and without HIV (WWH; WWoH) enrolled in the Women’s Interagency HIV Study and in follow-up on/after 2009 (when >80% of WWH consistently used…

1019 – Neurodevelopmental Disorders in French HIV-/ARV-Exposed Uninfected Children: A National Cohort Study

Background The health of uninfected children exposed to HIV requires long-term assessment, in particular, in terms of neurological and cognitive development. Numerous confounding factors have hampered such assessment, and the data are contradictory. Methods Using data from the French National Health Data System from 2012 to 2022, we conducted a population-based matched cohort study on…